HealthEquity, Inc.HQY
ASignal's systematic analysis rates HQY as Neutral.
Reflects the latest available analysis · analyzed Aug 28, 2026
The case on HQY
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong free cash flow of $370.33M indicating high-quality earnings
- High gross margin of 70.68% suggesting strong pricing power
- Low debt-to-equity ratio of 0.48x indicating solid financial health
- Current ratio of 3.44x reflecting strong liquidity position
- Earnings growth of 34.4% year-over-year signaling strong profitability expansion
- Forward P/E of 17.73x below current P/E of 35.01x, suggesting potential valuation improvement
- MACD below signal line with negative histogram, suggesting bearish momentum
- Price momentum negative at -0.052, indicating short-term downtrend
- Current price below 20-day and 50-day SMAs (bearish alignment)
- Low value score of 0.30 despite high growth, raising valuation concerns
- PEG ratio of 1.50x suggests stock may be overvalued relative to growth
See the full verdict on HQY
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes HQY
Most investors never get a second opinion, let alone several. ASignal runs HQY past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.